Responsibility
View all storiesLung Cancer
Lung cancer is the most common cancer and the leading cause of cancer death worldwide. The main types of lung cancer are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), which grow differently and are treated differently.
18/06/2021
MSD Switzerland awarded with the Swiss LGBTI Label
On June 16th 2021, MSD was awarded the with the Swiss LGBTI Label, a certification awarded to companies and organizations with an open and inclusive culture. This certification is intended to help promote the inclusion of LGBTI people at the workplace and beyond.
16/06/2021
The Ebola outbreak in the Democratic Republic of the Congo (DRC) is declared over
The 11th Ebola outbreak in the Democratic Republic of the Congo (DRC) is declared over nearly six months after the first cases were reported in Equateur Province
10/06/2021
Parallels of the HIV and COVID-19 pandemics
A conversation with MSD Chief Patient Officer Julie Gerberding, M.D., M.P.H., about her early work caring for people with HIV and AIDS, and the parallels of the AIDS and COVID-19 pandemics
06/06/2021
MSD continues to foster vibrant, creative workspaces as it launches new Zurich hub
A conversation with Klaus Beck, VP MSD Global Medical Affairs EMEAC, about MSD's new Innovation and Development Hub in Zurich.
28/04/2021
Addressing antibiotic resistance is more critical than ever. Here’s why.
Since their development, antibiotics have transformed health care and saved countless lives globally. But rising levels of antimicrobial resistance (AMR) make current antibiotics less effective.
23/04/2021
Things that count when parenting and working remotely during a pandemic
Stephanie Narain, Franchise Lead Lung, Business Unit Oncology at MSD Switzerland, shares her experiences and learnings of working from home as a mom and forging stronger connections with her colleagues despite the distance.
23/04/2021
Your questions answered: How MSD is responding to the global pandemic COVID-19
Learn more about what we’re doing to address COVID-19.
15/04/2021
Why we’re excited to partner on Johnson & Johnson’s COVID-19 vaccine
Our company has teamed with Johnson & Johnson to ramp up vaccine production – here’s what it means.
10/03/2021